BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 9641886)

  • 1. Resection and radiochemotherapy of pancreatic cancer--the future?
    Link KH; Formentini A; Leder G; Fortnagel G; Sartori N; Schatz M; Beger HG
    Langenbecks Arch Surg; 1998 Apr; 383(2):134-44. PubMed ID: 9641886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiotherapeutic strategies in the multimodal therapy of resectable and nonresectable pancreatic carcinoma].
    Wiegel T; Runkel N; Frommhold H; Rübe C; Hinkelbein W
    Strahlenther Onkol; 2000 Jul; 176(7):299-306. PubMed ID: 10962995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination therapy in oncology (multimodal treatment) in pancreatic tumors].
    Ihse I; Andersson R; Axelson J; Hansson L
    Chirurg; 1998 Apr; 69(4):366-70. PubMed ID: 9612618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy in operable pancreatic cancer.
    Wente MN; Büchler P; Friess H; Büchler MW
    Swiss Surg; 2002; 8(2):74-80. PubMed ID: 12013694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoadjuvant and adjuvant therapy of ductal pancreatic carcinoma].
    Hohenberger W; Kastl S
    Zentralbl Chir; 2000; 125(4):348-55. PubMed ID: 10829315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy for pancreatic cancer.
    Ghaneh P; Slavin J; Sutton R; Neoptolemos JP
    Swiss Surg; 2000; 6(5):289-95. PubMed ID: 11077498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of adjuvant chemoradiotherapy in the therapeutic strategy of exocrine adenocarcinoma of the pancreas].
    Mornex F; Partensky C; Bedenne L
    Cancer Radiother; 1997; 1(5):542-6. PubMed ID: 9587387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma.
    Lind PA; Isaksson B; Almström M; Johnsson A; Albiin N; Byström P; Permert J
    Acta Oncol; 2008; 47(3):413-20. PubMed ID: 17882555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant radiochemotherapy--what is the patients benefit?
    Link KH; Staib L; Schatz M; Suhr P; Röttinger E; Beger HG
    Langenbecks Arch Surg; 1998 Dec; 383(6):416-26. PubMed ID: 9921941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of lymph node positivity in treatment planning for early stage pancreatic cancer.
    Tran Cao HS; Zhang Q; Sada YH; Silberfein EJ; Hsu C; Van Buren G; Chai C; Katz MHG; Fisher WE; Massarweh NN
    Surgery; 2017 Sep; 162(3):557-567. PubMed ID: 28666686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery, radio- and chemotherapy for multimodal treatment of rectal cancer.
    Link KH; Staib L; Kornmann M; Formentini A; Schatz M; Suhr P; Messer P; Röttinger E; Beger HG;
    Swiss Surg; 2001; 7(6):256-74. PubMed ID: 11771444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pancreatic carcinoma. Optimizing therapy by adjuvant and neoadjuvant therapy?].
    Maurer CA; Zgraggen K; Büchler MW
    Zentralbl Chir; 1999; 124(5):401-7. PubMed ID: 10420525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adjuvant and neoadjuvant therapy of rectal carcinoma. The current status].
    Rödel C; Hohenberger W; Sauer R
    Strahlenther Onkol; 1998 Oct; 174(10):497-504. PubMed ID: 9810316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of surgery in pancreatic cancer.
    Buanes TA
    World J Gastroenterol; 2017 Jun; 23(21):3765-3770. PubMed ID: 28638216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
    Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
    Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
    Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carcinoma of the pancreas: current status of multimodal therapy].
    Keck T
    Zentralbl Chir; 2011 Aug; 136(4):352-8. PubMed ID: 21773958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.
    Neoptolemos JP; Stocken DD; Dunn JA; Almond J; Beger HG; Pederzoli P; Bassi C; Dervenis C; Fernandez-Cruz L; Lacaine F; Buckels J; Deakin M; Adab FA; Sutton R; Imrie C; Ihse I; Tihanyi T; Olah A; Pedrazzoli S; Spooner D; Kerr DJ; Friess H; Büchler MW;
    Ann Surg; 2001 Dec; 234(6):758-68. PubMed ID: 11729382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current state of adjuvant therapy in resected pancreatic adenocarcinoma.
    Bergenfeldt M; Albertsson M
    Acta Oncol; 2006; 45(2):124-35. PubMed ID: 16546857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.